Quick Listen: Scrip's Five Must-Know Things

 
• By Ian Haydock

In this week's episode: what Trump might mean for pharma; Novo’s semaglutide hits mark in NASH; AstraZeneca leads the way in clinical trials; Viking’s weight loss data excite; and how to speed up MLR reviews.

Scrip Five Must Know Things
weekly audio roundup of selected content from Scrip's global team

More from Scrip

More from Scrip's Five Must-Know Things